Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The <scp>DAPADream</scp> study - Concepedia

Concepedia

Publication | Closed Access

Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The <scp>DAPADream</scp> study

57

Citations

24

References

2020

Year

Torben Biester, Ido Muller, Thekla von dem Berge, Eran Atlas, Revital Nimri, Moshe Phillip, Tadej Battelino, Nataša Bratina, Klemen Dovč, Markus F. Scheerer,

Diabetes Obesity and Metabolism

Abstract

In adolescents and adults with T1D, dapagliflozin significantly increased TIR on average by 259 minutes/day while reducing glycaemic variability during FCL control without any signs of hypoglycaemia or ketosis.

References

	Year	Citations

Page 1